Showing results (211-220 of 2,105) with videos related to
Sort By:
Pageof 211
CNS Drugs|January 7, 2006
Treating depression in children and adolescents: what options now?Christopher K VarleyCNS Drugs|April 11, 2008
Aripiprazole in the treatment of depressive and anxiety disorders: a review of current evidenceChi-Un Pae, Alessandro Serretti, Ashwin A Patkar, et al.CNS Drugs|May 20, 2008
Restless legs syndrome: pathophysiology, diagnosis and treatmentPankaj Satija, William G OndoCNS Drugs|May 20, 2008
Intermittent subcutaneous apomorphine therapy for 'off' episodes in Parkinson's disease: a 6-month open-label studyRichard M Trosch, Dee Silver, Peter B BottiniCNS Drugs|December 13, 2007
Neurobiological and clinical effects of the antidepressant tianeptineSiegfried Kasper, Bruce S McEwenCNS Drugs|January 24, 2025
Targeting Kv7 Potassium Channels for EpilepsyEmilio Perucca, Maurizio TaglialatelaCNS Drugs|December 28, 2024
Safety and Efficacy of Ecopipam in Patients with Tourette Syndrome: A Systematic Review and Meta-analysisPrateek Kumar Panda, Pragnya Panda, Lesa Dawman, et al.CNS Drugs|December 5, 2024
Effects of One-Year Anti-seizure Treatment with Add-On Cenobamate on Bone Density and Bone Turnover in Adults with Drug-Resistant Focal Epilepsy: An Observational StudyYulia Novitskaya, Andreas Schulze-Bonhage, Elisa Schütz, et al.CNS Drugs|November 24, 2024
Measuring Disease Progression in Multiple Sclerosis Clinical Drug Trials and Impact on Future Patient CareFloriana De Angelis, Riccardo Nistri, Sarah WrightCNS Drugs|October 7, 2024
Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND StudyStewart J Tepper, Detlef Albrecht, Jessica Ailani, et al.Pageof 211